Skip to Main Content

Author Details

Francesco Favero
Universita del Piemonte Orientale
2010
28
17
PMIDPaper TitleJournal TitlePublished Year
37385999Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation.Cell Death Discov2023
35124694Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.Bone Marrow Transplant2022
35630335Proteome and Physiological Characterization of Halotolerant Nodule Endophytes: The Case of <i>Rahnella aquatilis</i> and <i>Serratia plymuthica</i>.Microorganisms2022
36001607A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease.PLoS One2022
36274067Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.Leukemia2022
36131938Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4<sup>+</sup> T cells.Front Immunol2022
35159043Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer.Cancers (Basel)2022
34151700Mutations known from B-cell lymphoid malignancies are not found in CD34<sup>+</sup> stem cells from patients with lymphoma.Leuk Lymphoma2021
34681001An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients.Genes (Basel)2021
32203146Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.Leukemia2020
31697811Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality.Blood2020
32181815Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.Blood2020
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
30066630STAble: a novel approach to de novo assembly of RNA-seq data and its application in a metabolic model network based metatranscriptomic workflow.BMC Bioinformatics2018
29978035Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer.NPJ Breast Cancer2018
28073006BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer.Cancer Cell2017
28939825Mitochondrial mutations drive prostate cancer aggression.Nat Commun2017
28097158Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.J Immunol Res2016
25319062Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.Ann Oncol2015
26461094Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.Cancer Cell2015
26429708TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.BMC Med Genomics2015
25877892Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.Sci Transl Med2015
26015868Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.Biomark Res2015
25732040Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.Ann Oncol2015
25159823Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.Genome Biol2014
219606643-(2,6-dimethylphenyl)-2-selenoxo-1,3-thiazolidin-4-one suppresses hydrogen peroxide-induced cytotoxicity on PC12 cells via activation of MAPK.Int J Toxicol2011
19502386MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.Am J Respir Cell Mol Biol2010
21209796Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.PLoS One2010
  • 1 - 28 of 28

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 11
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 0
Markus Ball
Institute of Pathology, Heidelberg University Hospital
Career Start Year 2010
Number of shared co-authors 0
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 6
Davide Prandi
University of Trento
Career Start Year 2009
Number of shared co-authors 1
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 1
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 18
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 8
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 0
Christina Curtis
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 6
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 21
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 26
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 7
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 1
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 13
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 8
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 6
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 12

Collaborators

Joachim Weischenfeldt
University of Copenhagen
Co-authored papers 8
Charles Swanton
Francis Crick Institute
Co-authored papers 5
Flavio Mignone
Co-authored papers 2
Christoph Plass
German Cancer Research Center
Co-authored papers 2
Thorsten Schlomm
Charite - University Hospital Berlin
Co-authored papers 2
Silvia Zucchelli
INFN Sezione di Bologna and University of Bologna
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Sandra D'Alfonso
Co-authored papers 2
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 2
Vyacheslav Amstislavskiy
Max-Planck-Institute for Molecular Genetics
Co-authored papers 1
Stefano Gustincich
Istituto Italiano di Tecnologia
Co-authored papers 1
John Z Sanborn
Co-authored papers 1
Clarissa Feuerstein
German Cancer Research Center (DKFZ), Heidelberg University
Co-authored papers 1
Gervaise H Henry
UT Southwestern Medical Center
Co-authored papers 1
Nikos Sidiropoulos
Rigshospitalet, University of Copenhagen
Co-authored papers 1
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
S??ren Matzk
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
James J Hsieh
Washington University
Co-authored papers 1
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Andrea L Richardson
Co-authored papers 1
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 1
Sara Busacca
University of Leicester, Robert Kilpatrick Clinical Sciences Building
Co-authored papers 1
Clarissa Gerh??user
German Cancer Research Center (DKFZ)
Co-authored papers 1
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 1
Federica Esposito
Co-authored papers 1
Release 1.2